United States: In a recent revelation, a significant majority of adults aged over 50 remain oblivious to the lurking menace of respiratory syncytial virus (RSV), with a startling six out of ten having never encountered the term, according to a groundbreaking survey conducted by GSK.
RSV, a highly contagious pathogen, stealthily infiltrates the nasal passages, throat, lungs, and airways, typically inducing mild, cold-like symptoms in otherwise healthy children and adults. However, this virus morphs into a potentially deadly adversary for vulnerable groups, including infants, the elderly, individuals with pre-existing respiratory or cardiac conditions, and those with compromised immune defenses, according to gsk.com.
Emerging as a leading culprit behind respiratory ailments in adults, RSV is estimated to precipitate over 5 million infections, 470,000 hospital admissions, and 33,000 in-hospital fatalities annually among those aged 60 and above in affluent nations.
Despite these alarming statistics, the GSK survey, which encompassed 3,516 participants from France, Canada, Australia, and Brazil, unveiled that 60% of respondents were blissfully unaware of RSV’s existence. Even more concerning, 56% of those who were unaware of RSV belonged to the demographic most susceptible to severe illness due to underlying health conditions.
“RSV stands as a formidable catalyst of respiratory distress in adults aged 50 and beyond, yet these findings underscore the pressing need for heightened awareness to fully comprehend the disease’s impact,” remarked Jane Barratt, Global Advisor for the International Federation on Ageing in Canada.
This knowledge gap implies that the true burden of RSV on public health remains grossly underestimated, leaving at-risk populations inadequately informed and potentially missing out on vital preventive measures.
The survey also shed light on the profound impact of respiratory viruses like RSV on the respondents. A staggering 70% of the participants reported grappling with a respiratory infection—be it COVID-19, influenza, or RSV—within the past year. Among these, 35% confessed that their recovery extended beyond two weeks.
Nearly two-thirds (65%) of those afflicted by a respiratory infection acknowledged that it disrupted their daily routines, while 31% reported a detrimental effect on their work capacity, as per reports.
The disclosure of this data coincides with the inauguration of GSK’s inaugural Global RSV Awareness Week, an initiative aimed at illuminating the risks posed by RSV and encouraging at-risk adults to consult their healthcare providers for further insights on the disease and strategies to mitigate its impact.
Adopting stringent respiratory hygiene practices, such as covering one’s mouth and nose with a handkerchief when coughing, donning face masks, and maintaining distance from unwell individuals, are among the crucial measures recommended to safeguard against infection.
Yan Sergerie, Global Medical Lead for RSV at GSK, emphasized the growing concern, stating, “As the global population continues to age, the ramifications of RSV are poised to escalate in the coming years,” as per the reports by gsk.com.
“With a significant portion of those at risk remaining uninformed about RSV, there is an urgent need for targeted educational initiatives and public health strategies to empower these vulnerable communities, enabling them to take proactive steps to thwart RSV.”
“We hope this pioneering Global RSV Awareness Week will inspire more individuals to engage with their healthcare professionals for guidance on reducing their susceptibility to the potentially severe consequences of RSV.”
